Andrew Reiter

Nessuna posizione attualmente

Health Technology

Profilo

Andrew Reiter is Chief Financial Officer of Akela Pharma, Inc. Previously, he was Chief Financial Officer of Silonex, Inc., Director of Finance/Corporate Controller for SR Telecom and Corporate Controller of The Yellow Pages Group.
He was Vice President of Finance and Administration for Dicom Express, Inc. and a Senior Manager of Deloitte & Touche.
Mr. Reiter is Chartered Accountant and received a Diploma in Public Accountancy from McGill University and a Bachelor of Commerce degree from Concordia University.

Precedenti posizioni note di Andrew Reiter

Società	Posizione	Fine
Akela Pharma, Inc. Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX.	Direttore Finanziario/CFO	14/08/2009

Vedi nel dettaglio l'esperienza di Andrew Reiter

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private